Thermage, Inc. Introduces Cellulite Product ThermaTip(TM) CL Designed to Improve the Appearance of Cellulite on the Thigh and Buttocks Area in a Single Treatment
HAYWARD, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Thermage, Inc. today announced the introduction of the ThermaTip(TM) CL treatment tip and the Cellulite procedure by Thermage at the American Academy of Dermatology's (AAD) annual meeting in San Antonio, Texas. The Cellulite procedure by Thermage uses the FDA cleared ThermaCool(R) system for the temporary improvement in the appearance of cellulite.
According to a study published in 2007 by the Millennium Research Group, nearly 90 percent of women experience some degree of cellulite, and demand for non-invasive cellulite treatments in the U.S. is expected to nearly double to over 750,000 procedures per year by 2011.
The Cellulite procedure by Thermage and the ThermaTip CL treatment tip are the result of 21 months of clinical and technology development. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to improve the smooth appearance of the skin's surface.
"Clinical evaluations have demonstrated that Thermage(R) technology noticeably reduces the appearance of cellulite after just a single treatment," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "We have conducted vigorous research since the spring of 2006 to develop a treatment tip that offers optimal results for our customers and their patients. The ThermaTip CL provides a unique option to physicians for the many patients who want to treat cellulite, but have yet to find something that produces significant results in a single treatment."
"Many of my patients have cellulite, and despite rigorous exercise and diet efforts, there is not much that they can do to minimize the appearance of cellulite," said Dr. Karyn Grossman, a cosmetic dermatologist with offices in Manhattan, NY and Santa Monica, CA. "I am thrilled to be able to offer patients an option for this condition that produces results in one treatment session without surgery, injections or downtime."
All Thermage procedures use a unique, patented monopolar capacitive radiofrequency technology for controlled heating of tissue that is backed by years of clinical research. The technology has been written about in over 45 peer-reviewed articles and safely used on over 450,000 patients worldwide to stimulate existing collagen and promote new collagen growth. Patients benefit from a single treatment and results can be subtle to dramatic depending on the individual patient.
In 2007 Thermage introduced the new ThermaCool(R) NXT(TM) system, which shortens procedure times and is more comfortable and flexible for practitioners to use than its predecessor system. The ThermaTip CL treatment tip is compatible with all existing ThermaCool systems.
About Thermage, Inc.
Thermage's innovative technologies provide unique non-invasive procedures designed to smooth, tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.
This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-Q for the period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
All our claims are based upon our FDA clearance for the non-invasive treatment of wrinkles and rhytids, including the upper and lower eyelids, and our FDA clearance for the temporary improvement in the appearance of cellulite.
Side effects are generally mild and may include redness, swelling, blisters, bumps and rare instances of surface irregularities.
Thermage, ThermaCool, NXT, ThermaTip and Body by Thermage are trademarks of Thermage, Inc.
rachel.martin@edelman.comjkirtland@evcgroup.com
CONTACT: media relations, Rachel Martin of Edelman, +1-323-202-1031,
rachel.martin@edelman.com; or investor relations, Jenifer Kirtland of EVC
Group, +1-415-896-6820, jkirtland@evcgroup.com
Web site: http://www.thermage.com/